Ambroxol hydrochloride composition and preparation thereof

A technology of ambroxol hydrochloride and its composition, which is applied in the field of medicine, can solve problems such as complex formulas and increased hidden dangers of drug safety, and achieve the effect of simple operation and enhanced safety performance

Active Publication Date: 2013-01-16
SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD +2
View PDF6 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Patent ZL200710059969.6 discloses an ambroxol hydrochloride injection, which is a stable pharmaceutical composition composed of ambroxol hydrochloride as the active ingredient and pharmaceutically acceptable carriers. These carriers include water-soluble fi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ambroxol hydrochloride composition and preparation thereof
  • Ambroxol hydrochloride composition and preparation thereof
  • Ambroxol hydrochloride composition and preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0027] Example 1:

[0028] An ambroxol hydrochloride composition comprising: 15 parts by weight of ambroxol hydrochloride, 50 parts by weight of mannitol, 1 part by weight of meglumine, and 0.05 parts by weight of disodium ethylenediaminetetraacetic acid.

[0029] The dosage form of the composition is injection, and each injection contains 15 mg of ambroxol hydrochloride, 50 mg of mannitol, 1 to mg of meglumine, 0.05 mg of disodium edetate, and water for injection to 2 ml.

[0030] The preparation method of the preparation is as follows: Dissolve the prescription amount of meglumine and mannitol in 80% water for injection by volume, and heat it to 35°C, then add the prescription amount of ambroxol hydrochloride, and stir it evenly. Add prescription amount of disodium ethylenediaminetetraacetic acid; add medical activated carbon at 30℃, filter, and then cool to normal temperature; add water for injection to the full amount, filter with 0.22μm pore filter membrane, and cool the filtrat...

Example Embodiment

[0031] Example 2:

[0032] An ambroxol hydrochloride composition comprising: 15 parts by weight of ambroxol hydrochloride, 150 parts by weight of mannitol, 1 part by weight of meglumine, and 0.5 parts by weight of disodium edetate.

[0033] The dosage form of the composition is injection, and each injection contains 15 mg of ambroxol hydrochloride, 150 mg of mannitol, 10 mg of meglumine, 0.5 mg of disodium edetate, and 2 ml of water for injection.

[0034] The preparation method of the preparation is as follows: dissolve the prescription amount of meglumine and mannitol in 70% water for injection by volume, and heat it to 35°C, then add the prescription amount of ambroxol hydrochloride, and stir it evenly. Add prescription amount of disodium ethylenediaminetetraacetic acid; add medical activated carbon at 30℃, filter, and then cool to normal temperature; add water for injection to the full amount, filter with 0.22μm pore filter membrane, and cool the filtrate to 5℃ before use Filter...

Example Embodiment

[0035] Example 3:

[0036] An ambroxol hydrochloride composition comprising: 15 parts by weight of ambroxol hydrochloride, 80 parts by weight of mannitol, 2 parts by weight of meglumine, and 0.08 parts by weight of disodium edetate.

[0037] The dosage form of the composition is injection, and each injection contains 15 mg of ambroxol hydrochloride, 80 mg of mannitol, 2 mg of meglumine, 0.08 mg of disodium edetate, and water for injection to 2 ml.

[0038] The preparation method of the preparation is as follows: Dissolve the prescription amount of meglumine and mannitol in 70% water for injection by volume and heat it to 30°C, then add the prescription amount of ambroxol hydrochloride, and stir it evenly. Add prescription amount of disodium ethylenediaminetetraacetic acid; add medical activated carbon at 35℃, filter, and then cool to normal temperature; add water for injection to full volume, filter with 0.22μm pore filter membrane, and cool the filtrate to 0℃ before use Filter with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicines and particularly relates to an ambroxol hydrochloride composition and a preparation thereof. The composition comprises the following components in parts by weight: 15 parts of ambroxol hydrochloride, 50-150 parts of mannitol, 1-10 parts of meglumine and 0.05-0.5 part of ethylene diamine tetraacetic acid disodium. The preparation is injection. Every injection contains 15mg of ambroxol hydrochloride, 50-150mg of mannitol, 1-10mg of meglumine, 0.05-0.5mg of ethylene diamine tetraacetic acid disodium and 2ml of water for injection. The invention provides the safe and stable ambroxol hydrochloride preparation. Proved by stability tests, the stability of the ambroxol hydrochloride preparation is superior to that of preparations in the prior art.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a composition of ambroxol hydrochloride and a preparation thereof. Background technique [0002] Ambroxol Hydrochloride (Ambroxol Hydrochloride), also known as Mu Shu Tan, is a respiratory lubricating expectorant and mucolytic drug, Ambroxol Hydrochloride, the chemical name is trans-4-[(2-amino-3,5- Dibromobenzyl)amino]cyclohexanol hydrochloride has the properties of promoting mucus elimination and dissolving secretions. It can promote the elimination of viscous secretions in the respiratory tract and reduce the retention of mucus, thus significantly promoting expectoration and improving respiratory condition. It can promote the secretion of pulmonary surfactant, the secretion of airway fluid and the movement of cilia. Ambroxol hydrochloride is widely used clinically for thick sputum and difficulty expectoration caused by various acute and chronic respiratory disea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/26A61K47/18A61K31/137A61K9/08A61P11/10
Inventor 李明杰郭中明杨磊祥牛洪芬
Owner SHANDONG LUOXIN PARMACEUTICAL GROUP STOCK CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products